Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled SNG001 for COVID-19
NCT04385095Phase 2Completed
- Sponsor
- Synairgen
- Start
- Mar 2020
- Primary completion
- Feb 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1a in coronavirus disease 2019 (COVID-19), sponsored by Synairgen. Started Mar 2020; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04385095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04385095.